347 related articles for article (PubMed ID: 29197669)
1. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy.
Durá-Travé T; Gallinas-Victoriano F; Malumbres-Chacón M; Moreno-Gónzalez P; Aguilera-Albesa S; Yoldi-Petri ME
Epilepsy Res; 2018 Jan; 139():80-84. PubMed ID: 29197669
[TBL] [Abstract][Full Text] [Related]
2. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
Kanemura H; Sano F; Ohyama T; Aihara M
Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
[TBL] [Abstract][Full Text] [Related]
4. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
[TBL] [Abstract][Full Text] [Related]
5. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
[TBL] [Abstract][Full Text] [Related]
7. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.
Söylemez E; Öztürk O; Baslo SA; Balçık ZE; Ataklı D
Epilepsy Behav; 2020 Oct; 111():107296. PubMed ID: 32769040
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
10. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy.
Sreedharan M; Devadathan K; Mohammed Kunju PA; Sasidharan B; Pillai JP; Vasumathy Amma MA; Muthubeevi S
Indian Pediatr; 2018 Apr; 55(4):307-310. PubMed ID: 29428922
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
13. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
Guo Y; Lin Z; Huang Y; Yu L
Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
[TBL] [Abstract][Full Text] [Related]
14. Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis.
Ilia TS; Dragoumi P; Papanikolopoulou S; Goulis DG; Pavlou E; Zafeiriou D
Seizure; 2022 Jan; 94():117-125. PubMed ID: 34896814
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS).
Xiao F; An D; Deng H; Chen S; Ren J; Zhou D
Seizure; 2014 Oct; 23(9):756-61. PubMed ID: 24998415
[TBL] [Abstract][Full Text] [Related]
16. Reproductive endocrine health in pubertal females with epilepsy on antiepileptic drugs: time to screen?
Rauchenzauner M; Roscia S; Prieschl M; Wildt L; Haberlandt E; Baumann M; Rostasy K; Agostinelli S; Pizzolorusso A; Luef G; Verrotti A
Neuropediatrics; 2014 Aug; 45(4):226-33. PubMed ID: 24407471
[TBL] [Abstract][Full Text] [Related]
17. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of anti-epileptic drugs-an internet study.
Wieshmann UC; Baker G
Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
[TBL] [Abstract][Full Text] [Related]
19. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.
Albaghdadi O; Alhalabi MS; Alourfi Z; Youssef LA
Clin Neurol Neurosurg; 2016 Jul; 146():52-6. PubMed ID: 27150607
[TBL] [Abstract][Full Text] [Related]
20. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
Tumay Y; Altun Y; Ekmekci K; Ozkul Y
Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]